IPO registrations (S-1, F-1) · Registrants

KING PHARMACEUTICALS INC

SEC CIK
1047699 · filings on EDGAR ↗
Registration
Form S-1, first filed 1997-10-24, last 1998-06-25; 1 initial registration, 9 amendments
Outcome
No final prospectus, effectiveness notice or withdrawal within two years of the registration
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
TN
Business address
501 FIFTH ST, Bristol, TN 37620
EIN
54-1684963
EDGAR entity type
operating
Insiders and CEO pay
KING PHARMACEUTICALS INC on the corporate pages

Offering terms

Shares offered
6,250,000
Listing
Nasdaq under the symbol KING

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 10

FiledFormWhat it isName as filedEDGAR
1997-10-24S-1S-1 (registration)KING PHARMACEUTICALS INC0000950123-97-008871 ↗
1997-11-04S-1/AS-1/A (amendment)KING PHARMACEUTICALS INC0000950123-97-009127 ↗
1997-12-05S-1/AS-1/A (amendment)KING PHARMACEUTICALS INC0000950144-97-013083 ↗
1997-12-08S-1/AS-1/A (amendment)KING PHARMACEUTICALS INC0000950144-97-013137 ↗
1997-12-09S-1/AS-1/A (amendment)KING PHARMACEUTICALS INC0000950144-97-013185 ↗
1998-01-09S-1/AS-1/A (amendment)KING PHARMACEUTICALS INC0000950144-98-000174 ↗
1998-05-07S-1/AS-1/A (amendment)KING PHARMACEUTICALS INC0000950144-98-005627 ↗
1998-05-22S-1/AS-1/A (amendment)KING PHARMACEUTICALS INC0000950144-98-006799 ↗
1998-06-02S-1/AS-1/A (amendment)KING PHARMACEUTICALS INC0000950144-98-007081 ↗
1998-06-25S-1/AS-1/A (amendment)KING PHARMACEUTICALS INC0000950123-98-006226 ↗

Prospectus pages read 1

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
1998-06-25S-1/Aregistration statement$100.006,250,000$625,000,000Nasdaq KING0from the submission text; price sentence, shares headline, proceeds computeddocument ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ROOKER D GREGORYDirector142006–2011
Elrod James WOfficerChief Legal Officer, A. Sec.; Chief Legal Officer, Secretary; General Counsel and Corp. Sec.242006–2011
ANDRZEJEWSKI STEPHEN JOfficerChief Commercial Officer192006–2010
BROUILLETTE FREDERICK JROfficerCorporate Compliance Officer282006–2011
BRUCE ERIC JOfficerChief Tech Ops Ofcr; President, Animal Health242006–2011
GREEN JAMES EOfficerExec Vice Pres Corp Affairs122006–2009
MARKISON BRIAN ADirector,OfficerPresident and CEO262006–2011
Squicciarino JosephOfficerChief Financial Officer282006–2011
DEAVENPORT EARNEST W JRDirector72006–2011
GREETHAM ELIZABETH MDirector92006–2011
JORDAN GREGORY DDirector72006–2011person page Fuzzy
MOYER CHARLESDirector142006–2011
PFEFFER PHILIP MDirector12006
WOOD TED GDirector82006–2011
INCARNATI PHILIP ADirector72006–2011
Carter Eric GOfficerChief Science Officer232007–2011
Crutchfield Kevin SDirector42010–2011
SCHAFFER DERACE LDirector42010–2011
Bailey Jeffrey AllenOfficerChief Commercial Officer42010–2011
Giordano Douglas E.Director12011
LEPORE MATTHEWDirector12011
Parker Tennessee Corp.TenPercentOwner12011
PECK KRISTIN CDirector12011
PFIZER INCTenPercentOwner12011
Reid DavidDirector12011
SUPRAN BRYANDirector12011

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationKing Pharmaceuticals, Inc.TNState business registriesname and state
Political committeeKING PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEE (connected to KING PHARMACEUTICALS, INC.)TNCampaign finance (FEC)name and state
Federal award recipientKING PHARMACEUTICALS, INC.TNFederal spending (USAspending)name and state
Lobbying clientKING PHARMACEUTICALS INCTNFederal lobbying (LDA)name and state
SEC filerKING PHARMACEUTICALS INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerKing Pharmaceuticals, Inc.TNTrademarks (USPTO)name and state
Form 5500 plan sponsorKING PHARMACEUTICALS, INC. C/O PFIZER INC.EIN (EXACT)
Person pageDr Gregory D JordanPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, TN first:

More with this interest.

In other datasets, the same topic (Health) in TN:

Interests: Pharmaceutical Preparations · Health